T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 | +$1.82B | |
| 2 | +$1.38B | |
| 3 | +$1.16B | |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| 1 | +$4.73B | |
| 2 | +$3.54B | |
| 3 | +$1.75B | |
| 4 |
Amphenol
APH
|
+$1.65B |
| 5 |
KLA
KLAC
|
+$1.5B |
Sector Composition
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Immunocore
IMCR
$1.46B
| $27.7M | ﹤0.01% |
919,332
-49,452
|
|
||
952
Five Below
FIVE
$11.2B
| $27.6M | ﹤0.01% |
120,979
+70,128
|
|
||
953
Camtek
CAMT
$8.48B
| $27.6M | ﹤0.01% |
+182,230
|
|
||
954
StoneCo
STNE
$2.74B
| $27.5M | ﹤0.01% |
1,947,595
-292,382
|
|
||
|
BCAX
955
Bicara Therapeutics
BCAX
$1.4B
| $27.4M | ﹤0.01% |
1,376,198
-183,337
|
|
||
956
Lennar Class A
LEN
$23.4B
| $27.3M | ﹤0.01% |
314,722
-12,545
|
|
||
957
HF Sinclair
DINO
$12.6B
| $27.3M | ﹤0.01% |
437,955
+72,907
|
|
||
958
Babcock & Wilcox
BW
$2.36B
| $27.2M | ﹤0.01% |
+1,853,633
|
|
||
959
Alarm.com
ALRM
$2.3B
| $27.2M | ﹤0.01% |
629,489
-266,130
|
|
||
960
Sprouts Farmers Market
SFM
$8.29B
| $27.2M | ﹤0.01% |
352,372
-92,929
|
|
||
|
RAPP
961
Rapport Therapeutics
RAPP
$1.68B
| $27.1M | ﹤0.01% |
866,456
-15,153
|
|
||
962
International Flavors & Fragrances
IFF
$19.8B
| $27.1M | ﹤0.01% |
373,663
-1,920
|
|
||
963
T. Rowe Price
TROW
$23.2B
| $27M | ﹤0.01% |
300,012
-13,910
|
|
||
964
Expeditors International
EXPD
$21.8B
| $27M | ﹤0.01% |
188,430
-10,151
|
|
||
965
Vale
VALE
$65.5B
| $27M | ﹤0.01% |
1,696,209
+211,173
|
|
||
966
Bunge Global
BG
$24.3B
| $27M | ﹤0.01% |
212,065
+8,630
|
|
||
967
SBA Communications
SBAC
$21.6B
| $26.8M | ﹤0.01% |
155,849
-135,167
|
|
||
|
HOLX
968
DELISTED
Hologic
HOLX
| $26.8M | ﹤0.01% |
353,877
-8,796
|
|
||
969
Charter Communications
CHTR
$17.1B
| $26.7M | ﹤0.01% |
123,660
-1,473
|
|
||
970
Noble Corp
NE
$7.36B
| $26.7M | ﹤0.01% |
543,475
+432,069
|
|
||
971
Crane Co
CR
$11.8B
| $26.6M | ﹤0.01% |
155,623
-34,911
|
|
||
972
T. Rowe Price US Equity Research ETF
TSPA
$3.45B
| $26.5M | ﹤0.01% |
648,407
|
|
||
|
GENB
973
Generate Biomedicines
GENB
$1.66B
| $26.4M | ﹤0.01% |
+2,109,633
|
|
||
974
SSR Mining
SSRM
$5.46B
| $26.3M | ﹤0.01% |
893,320
+775,699
|
|
||
|
LINE
975
Lineage Inc
LINE
$10.1B
| $26.3M | ﹤0.01% |
801,315
-65,138
|
|